Pharmaceuticals

BAVENCIO Pivotal Phase III JAVELIN Bladder 100 Results Published in The New England Journal of Medicine

Not intended for US-, Canada- and UK-based media DARMSTADT, Germany, and NEW YORK, Sept. 18, 2020 /PRNewswire/ -- Merck and Pfizer Inc. (NYSE: PFE) today announced the publication of detailed results from the Phase III JAVELIN Bladder 100 study online ahead of print inThe New England Journal of...

2020-09-18 15:00 4539

First patient in treatment in RhoVac's clinical phase IIb study in Sweden

STOCKHOLM, Sept. 17, 2020 /PRNewswire/ --  RhoVac AB ("RhoVac") announces today, onSeptember 17 2020, that the first patient in Sweden is enrolled in the company's clinical phase IIb study in prostate cancer, a study named RhoVac-002 ("BRaVac"). The first patient in Sweden is enrolled in the cli...

2020-09-17 23:51 1978

Viva Biotech's Portfolio Company Dogma Therapeutics Reached the Acquisition Agreement with AstraZeneca on Dogma's Oral PCSK9 Inhibitor Program

CAMBRIDGE, Mass., Sept. 17, 2020 /PRNewswire/ -- Dogma Therapeutics ("Dogma"), a Viva Biotech Portfolio Company, has reached an agreement for the acquisition of its oral PCSK9 program by AstraZeneca. Dogma will receive upfront as well as downstream payments linked to global regulatory and commerc...

2020-09-17 20:25 2043

Alter Pharma Group Adopts Movilitas.Cloud to Ensure Safer Goods and EU FMD Compliance Throughout the Product Path and Changes in Packaging

Solution supports requirements for traceability down to the single package level and optimizes the repackaging process for increased efficiency and safer medicine COLUMBIA, Maryland, Sept. 16, 2020 /PRNewswire/ -- Movilitas announced that the Alter Pharma Group, a pharmaceutical group active in ...

2020-09-16 21:39 1733

Sanofi partners with Health2Sync to deliver an innovative digital solution to patients and healthcare providers, paving the way for digital therapeutics in diabetes

* Starting in Taiwan, this partnership aims to on-board clinics and hospitals nationwide over the next 3 years * Health2Sync to provide patient management software, patient app, and analytics to facilitate smart insulin management * Bi-lateral digital touchpoints empower patients with person...

2020-09-16 19:12 776

CIRT-EU Registry for SIR-Spheres(R) Therapy presented at CIRSE 2020 Summit

Largest European-wide observational, multicenter registry of SIR-Spheres Y-90 resin microspheres for liver tumors conducted by CIRSE reports safety and survival data WOBURN, Mass., Sept. 15, 2020 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies...

2020-09-15 20:00 1455

Sihuan Pharmaceutical (0460.HK): Under innovation transformation, an internationalized new pattern in construction

HONG KONG, Sept. 15, 2020 /PRNewswire/ -- Recently, share price of Sihuan Pharmaceutical (0460.HK) continued to rise, hittingHK$1.09 per share, up 53.52% from its low onMay 25. Judging from the stock price trend, the stock price of Sihuan Pharmaceutical seems to have entered the stage of reboundi...

2020-09-15 18:05 4238

Elekta introduces new radiotherapy solution to help address worldwide cancer burden

- Elekta Harmony to shorten treatment times and reduce footprint while maintaining high precision STOCKHOLM, Sept. 15, 2020 /PRNewswire/ -- Elekta (EKTA-B.ST) today introduced its Elekta Harmony* linear accelerator (linac), a cancer treatment system designed to meet healthcare centers' need for ...

2020-09-15 18:03 8516

MAGHREB PHARMA Expo to contribute to Algeria plans to export for US$ 5 billion locally produced drugs by 2025

ALGIERS, Algeria, Sept. 15, 2020 /PRNewswire/ --Easyfairs Northeral, the organizer of MAGHREB PHARMA Expo has announced new dates for its annual international tradeshow for the pharmaceutical industry inNorth Africa. In this context, the Algerian Pharmaceutical Industry Minister,Lotfi Benbahmed, ...

2020-09-15 14:00 1444

Standigm Partners with Excelra for GOSTAR to Enhance its AI-driven Drug Discovery Process

HYDERABAD, India and SEOUL, South Korea, Sept. 15, 2020 /PRNewswire/ -- Excelra , a global data science and data analytics company, today announced its collaboration with Standigm Inc., a company using artificial intelligence (AI) technology for drug discovery and develo...

2020-09-15 10:00 1571

Concept Medical announces index patient enrolment in world's first Randomized Controlled Trial with Sirolimus Coated Balloon for the treatment of Superficial Femoral Artery (SFA) in Peripheral Artery Disease

SINGAPORE, Sept. 15, 2020 /PRNewswire/ -- Concept Medical Inc., focused on vascular intervention drug delivery devices, has announced the enrolment of the first patient in theFUTURE SFA (Randomized Controlled Trial ofFirst SirolimUs CoaTed Balloon VersUs StandaRd ...

2020-09-15 03:41 1584

TIKOMED'S ILB(R) restores brain energy metabolism following severe traumatic brain injury in the rat demonstrated in data published by the journal Antioxidants

VIKEN, Sweden, Sept. 14, 2020 /PRNewswire/ -- A new study on TIKOMED's lead drug candidate, ILB®, addressing one of the underlying causes of neurodegeneration in acute and chronic diseases was published in Antioxidants today. The data from the rodent model studying severe traumatic brain injury ...

2020-09-14 20:35 1357

Ascentage Pharma's MDM2-p53 Inhibitor APG-115 Granted Orphan Drug Designation by the FDA for the Treatment of Gastric Cancer

SUZHOU, China and ROCKVILLE, Md., Sept. 14, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the US Food and Drug ...

2020-09-14 18:35 690

Countering counterfeit medicines in the fast-paced world of e-commerce

BANGKOK, Sept. 14, 2020 /PRNewswire/ -- Research shows that counterfeit medicine cannot cure illnesses and can cause moreharm to your health. Counterfeit medicines have been in the market for a long time, and without sufficient awareness, consumption of these substances can lead to unexpected sy...

2020-09-14 16:59 1434

Merck Advances Oncology Portfolio and Pipeline with New and Long-term Data in Multiple Cancers at ESMO 2020

* New analyses from Phase III JAVELIN Bladder 100 study of BAVENCIO®* assess efficacy across subgroups, patient-reported outcomes and exploratory biomarkers in advanced urothelial cancer * Overall efficacy data, and analyses of brain metastases and HRQoL for tepotinib† from largest ongoing st...

2020-09-14 10:41 1664

Gannex Filed US IND for Its NASH Drug ASC42, an FXR Agonist

SHANGHAI, Sept. 14, 2020 /PRNewswire/ -- Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX:1672) announces today that it has filed investigational new drug application (IND) with US FDA for its non-alcoholic steatohepatitis (NASH) drug candidate ASC42. ASC42 is an in-...

2020-09-14 08:30 1924

Virtual reality startup and Fujitsu bring immersive drug design software to Japanese market

SAN DIEGO, Sept. 14, 2020 /PRNewswire/ -- San Diego–based virtual reality (VR) startup Nanome, Inc. has entered into an agreement with Fujitsu to bring their signature product—an immersive scientific design and collaboration platform—to the Japanese market. The software is already used by more th...

2020-09-14 08:17 2271

SK Biopharmaceuticals Initiates Clinical Development Program for Cenobamate in Asia

Phase 3 clinical trial to support registrational filings in China and Japan Company on track to expand presence in Asia, reflecting its commitment to reach more people with epilepsy worldwide PANGYO, GYEONGGI PROVINCE, Korea, Sept. 12, 2020 /PRNewswire/ -- SK Biopharmaceuticals, Co., Ltd., a glo...

2020-09-12 03:13 4636

New MAVENCLAD® Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting Highlight Rapid Onset of Action and Compelling Post-Approval Safety

In MAGNIFY-MS, patients experienced a rapid onset of action from end of Month 1 that was significant in all study periods versus baseline Post-approval safety analysis showed no increased risk of viral respiratory infections and lower rates of malignancy than in the clinical trial program Data f...

2020-09-11 20:00 4675

Sai Life Sciences expands suite of cellular analysis platforms in Cambridge, MA

CAMBRIDGE, Mass. and HYDERABAD, India, Sept. 11, 2020 /PRNewswire/ --  Sai Life Sciences, one ofIndia's fastest growing Contract Development & Manufacturing Organizations (CDMOs) , today ann...

2020-09-11 11:30 2647
12345 ... 84